In silico drug repurposing for coronavirus (COVID-19): screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensin-converting enzyme 2 (ACE2) (6M0J)

[1] Gorbalenya AE(2020)The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Nat Microbiol 5 536-544

[2] Baker SC(2020)Will novel virus go pandemic or be contained? Science 367 610-611

[3] Baric RS(2017)Global patterns in coronavirus diversity Virus Evol 3 1-15

[4] Kupferschmidt K(2016)Epidemiology, genetic recombination, and pathogenesis of coronaviruses Trends Microbiol 24 490-502

[5] Cohen J(2019)A novel coronavirus from patients with pneumonia in China N Engl J Med 382 727-733

[6] Anthony SJ(2020)An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov) Infect Dis Model 5 248-255

[7] Johnson CK(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-273

[8] Greig DJ(2020)Drug development and medicinal chemistry efforts toward SARS-coronavirus and covid-19 therapeutics ChemMedChem 15 1-27

[9] Kramer S(2020)Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study Life Sci 253 117592-117598

[10] Che X(2020)In silico studies on therapeutic agents for COVID-19: drug repurposing approach Life Sci 252 117652-117664

[1] Gorbalenya AE(2020)The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Nat Microbiol 5 536-544

[2] Baker SC(2020)Will novel virus go pandemic or be contained? Science 367 610-611

[3] Baric RS(2017)Global patterns in coronavirus diversity Virus Evol 3 1-15

[4] Kupferschmidt K(2016)Epidemiology, genetic recombination, and pathogenesis of coronaviruses Trends Microbiol 24 490-502

[5] Cohen J(2019)A novel coronavirus from patients with pneumonia in China N Engl J Med 382 727-733

[6] Anthony SJ(2020)An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov) Infect Dis Model 5 248-255

[7] Johnson CK(2020)A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270-273

[8] Greig DJ(2020)Drug development and medicinal chemistry efforts toward SARS-coronavirus and covid-19 therapeutics ChemMedChem 15 1-27

[9] Kramer S(2020)Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study Life Sci 253 117592-117598

[10] Che X(2020)In silico studies on therapeutic agents for COVID-19: drug repurposing approach Life Sci 252 117652-117664